Profile of Fournier gangrene patients using hyperbaric oxygen therapy as an adjuvant treatment
DOI:
https://doi.org/10.11606/issn.2176-7262.v53i1p21-25Keywords:
Fournier Gangrene, Hyperbaric Oxygenation, Combined Modality TherapyAbstract
Objective: Evaluating the results obtained from hyperbaric oxygen therapy (HBOT) as an adjuvant treatment in Fournier's Gangrene (GF). Casuistic and Method: Cross-sectional, retrospective, and descriptive study based on the analysis of physical records of patients with GF submitted to hyperbaric oxygen therapy through the hyperbaric chamber from February 2008 to May 2018, assisted at the hyperbaric oxygen therapy clinic, in Bauru, SP. The data collected were age, gender, etiology, comorbidities, lesion location and extension, total session number, and mortality. Result: It totaled 38 patients, 76% male, with a mean age of 55.6 years. Among the patients, 17 (44.7%) were discharged, 18 (47.4%) discontinued treatment before termination, and three (8.21%) deaths occurred. The main etiology was an abscess and the main predisposing comorbidities were diabetes mellitus and hypertension. The location and extension lesion with the most affected areas were in the scrotal region, followed by the perineal region. Conclusion: The results of this study demonstrated that the effect of HBOT as an adjuvant treatment has an advantage in the treatment of GF resulting in considerable patient medical discharge and low mortality.
Downloads
References
2. Cardoso JB, Féres O. Gangrena de Fournier. Medicina (Ribeirão Preto). 2007;40(4): 493-9. doi: 10.11606/issn.2176-7262.v40i4p493-499
3. Dornelas MT, Correa MPD, Barra FML, Corrêa LD, Silva C, Dornelas GV, et al. Síndrome de Fournier: 10 anos de avaliação. Rev Bras Cir Plast. 2012;27(4):600-4. doi: 10.1590/S1983-51752012000400022
4. Sroczyński M, Sebastian M, Rudinicki J, Sebastian S, Agrawal AK. A complex approach to the treatment of Fournier’s gangrene. Adv Clin Exp Med. 2013;22(1):407-10.
5. Santos DR, Roman ULT, Westphalen AP, Lovison K, Spencer NFAC. Profile of patients with Fournier’s gangrene and their clinical evolution. Rev Col Bras Cir. 2018;45(1):e1430. doi: 10.1590/0100-6991e-20181430
6. Benjelloun EB, Souiki T, Yakla N, Ousaddean A, Mazaz K, Louchi A, et al. Fournier's gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg. 2013;8(1):13. doi: 10.1186/1749-7922-8-13
7. Rosa I, Guerreiro F. Hyperbaric oxygen therapy for the treatment of Fournier’s gangrene: a review of 34 cases. Acta Med Port. 2015; 28:619–23. doi: 10.20344/amp-6300
8. Hung MC, Chou CL, Cheng LC, Ho CH, Niu KC, Chen HL, et al. The role of hyperbaric oxygen therapy in treating extensive Fournier's gangrene. Urol Sci. 2016;27:148-153. doi: 10.1016/j.urols.2015.06.294
9. Pastore AL, Palleschi G, Ripoli A, Silvestri L, Leto A, Autieri D, et al. A multistep approach to manage Fournier's gangrene in a patient with unknown type II diabetes: surgery, hyperbaric oxygen, and vacuum-assisted closure therapy: a case report. J Med Case Rep. 2013;7:1. doi: 10.1186/1752-1947-7-1
10. Ferretti M, Saji AA, Phillips J. Fournier's Gangrene: A Review and Outcome Comparison from 2009 to 2016. Adv Wound Care. 2017;6(9):289–95. doi: 10.1089/wound.2017.0730
11. Mehl AA, Nogueira Filho DC, Mantovani LM, Grippa MM, Berger R, Krauss D, et al. Manejo da gangrena de Fournier: experiência de um Hospital Universitário de Curitiba. Rev Col Bras Cir. 2010;37(6). doi: 10.1590/S0100-69912010000600010
12. Devaney B, Frawley G, Frawley L, Pilcher DV. Necrotizing soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth Intensive Care. 2015;43(6):685-92. doi: 10.1177/0310057X1504300604
13. Gandhi J, Seyam O, Smith NL, Joshi G, Vatsia S, Khan SA. Clinical utility of hyperbaric oxygen therapy in genitourinary medicine. Med Gas Res. 2018;8(1):29-33. doi: 10.4103/2045-9912.229601
14. Anheuser P, Mühlstädt S, Kranz J, Schneidewind L, Steffens J, Fornara P. Significance of Hyperbaric Oxygenation in the Treatment of Fournier’s Gangrene: A comparative Study. Urol Int. 2018;101(4):467-71. doi: 10.1159/000493898
15. Li C, Zhou X, Liu LF, Qi F, Chen JB, Zu XB. Hyperbaric oxygen therapy as an adjuvant therapy for comprehensive treatment of Fournier's gangrene. Urol Int. 2015;94:453-458. doi: 10.1159/000366137
16. Sorensen MD, Krieger JN: Fournier’s Gangrene: epidemiology and outcomes in the general US population. Urol Int. 2016;97:249–59. doi: 10.1159/000445695
Downloads
Published
Issue
Section
License
